Ancora Advisors LLC Raises Position in ZimVie Inc. $ZIMV

Key Points

• Ancora Advisors LLC significantly increased its stake in ZimVie Inc. by 140.1%, owning 269,290 shares worth approximately $2.9 million.
• Other institutional investors like J. Goldman & Co LP and Gamco Investors INC. also increased their holdings, contributing to 95.63% institutional ownership of ZimVie.
• ZimVie recently reported earnings of $0.26 EPS, surpassing analyst expectations, and has received mixed ratings from analysts with a consensus rating of "Hold" and an average target price of $17.75.

Ancora Advisors LLC boosted its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 140.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 269,290 shares of the company's stock after acquiring an additional 157,130 shares during the quarter. Ancora Advisors LLC owned 0.97% of ZimVie worth $2,908,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. J. Goldman & Co LP grew its position in ZimVie by 167.5% in the 4th quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company's stock worth $19,890,000 after purchasing an additional 892,785 shares during the period. Gamco Investors INC. ET AL lifted its holdings in ZimVie by 22.6% during the first quarter. Gamco Investors INC. ET AL now owns 636,341 shares of the company's stock valued at $6,872,000 after purchasing an additional 117,229 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in ZimVie by 9.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company's stock worth $17,367,000 after buying an additional 107,461 shares during the period. Nuveen LLC bought a new position in ZimVie in the 1st quarter worth $901,000. Finally, American Century Companies Inc. lifted its position in shares of ZimVie by 10.0% in the first quarter. American Century Companies Inc. now owns 690,675 shares of the company's stock valued at $7,459,000 after acquiring an additional 62,625 shares in the last quarter. 95.63% of the stock is currently owned by institutional investors.

ZimVie Trading Down 0.4%

Shares of ZIMV opened at $18.86 on Thursday. The stock has a market capitalization of $531.85 million, a PE ratio of -26.94 and a beta of 2.19. The company's fifty day moving average is $15.61 and its 200 day moving average is $12.07. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.60 and a current ratio of 2.37. ZimVie Inc. has a fifty-two week low of $8.15 and a fifty-two week high of $19.01.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.05. ZimVie had a negative net margin of 4.39% and a positive return on equity of 6.37%. The business had revenue of $116.66 million during the quarter, compared to analysts' expectations of $112.60 million. Sell-side analysts expect that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Wall Street Zen cut ZimVie from a "strong-buy" rating to a "buy" rating in a research report on Friday, July 18th. B. Riley lowered shares of ZimVie from a "buy" rating to a "neutral" rating and set a $19.00 price objective for the company. in a report on Thursday, July 31st. UBS Group reduced their price objective on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research report on Thursday, May 15th. Finally, Barclays upgraded shares of ZimVie from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $9.00 to $19.00 in a research report on Tuesday, July 22nd. Four research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $17.75.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.